Description:UNC2250, with the CAS number 1493694-70-4, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential applications in cancer research. It is classified as a small molecule inhibitor, specifically targeting certain protein interactions that are crucial for tumor growth and proliferation. The compound exhibits a unique structure that allows it to interact selectively with its biological targets, which may lead to the modulation of signaling pathways involved in cancer progression. UNC2250 has been studied for its efficacy in preclinical models, demonstrating promising results in inhibiting the growth of various cancer cell lines. Its pharmacokinetic properties, including solubility and stability, are also important for its development as a therapeutic agent. Ongoing research aims to further elucidate its mechanism of action, optimize its chemical properties, and evaluate its safety and effectiveness in clinical settings. Overall, UNC2250 represents a significant advancement in the search for targeted cancer therapies.
Applications (1r,4r)-4-((2-(Butylamino)-5-(5-(morpholinomethyl)pyridin-2-yl)pyrimidin-4-yl)amino)cyclohexanol inhibits steady-state phosphorylation of endogenous Mer and blocks ligand-stimulated activation of a chimeric …
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
